A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism

Fertility and Sterility

Volumn 68, Issue 4, 1997, Pages 644-647

  Müderris, Iptisam Ipek ^a   Bayram, Fahri ^a   Şahin, Yilmaz ^a   Keleştimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Flutamide therapy; Hirsutism

Indexed keywords

FLUTAMIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HIRSUTISM; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0343581299     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00266-5     Document Type: Article

References (16)

1. Delahunt JW. Hirsutism. Drugs 1993;45:223-31.
2. Kirschner MA, Zucker IR, Jespersen D. Idiopathic hirsutism: an ovarian abnormality. N Engl J Med 1976;294:637-40.
3. Cusan L, Dupont A, Belanger A, Tremblay RR, Manhes G, Labrie F. Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 1990;23:462-9.
4. Simard J, Luthy I, Guay J, Belanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 1986;44:261-70.
5. Brochu M, Belanger A, Dupont A, Cusan L, Labrie F. Effects of flutamide and aminoglutethimide on plasma 5 α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. J Steroid Biochem 1987;28:619-22.
6. Cesur V, Kamel N, Uysal AZ, Erdoǧan G, Başkai N. The use of antiandrogen flutamide in the treatment of hirsutism. Endocr J 1994;41:573-7.
7. Marcondes JAM, Minnani SL, Luthold WW, Bernardo LW, Samojlik E, Kirschner MA. Treatment of hirsutism in women with flutamide. Fertil Steril 1992;57:543-7.
8. Müderris II, Bayram F, Şahin Y, Keleştimur F, Tutuş A, Ayata D. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism. Fertil Steril 1996;66:220-2.
9. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-26.
10. Cusan L, Dupont A, Gomez J-L, Tremblay RR, Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil Steril 1994; 61:281-7.
11. Moghetti P, Castello R, Negri C, Tosi F, Magnani CM, Fontanarosa MC, et al. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 1995;64:511-7.
12. Erenus M, Gürbüz O, Durmuşoǧlu F, Demirçay Z, Pekin S. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril 1994;61:613-6.
13. Gomez JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lemay M, et al. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 1992;92:465-70.
14. Luthy L, Caron S, Belanger A, Labrie F. Effect of flutamide, a pure antiandrogen, on endocrine parameters in the adult female rat. Gynecol Endocrinol 1987;1:151-68.
15. Couzinet B, Pholsena M, Young J, Schaison G. The impact of a pure anti-androgen flutamide on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clin Endocrinol (Oxf) 1993;39:157-62.
16. Dodin S, Faure N, Cedrin I, Mechain C, Turcot-Lemay L, Guy J, et al. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol 1995;43:575-82.